litlas
ログインアカウント作成

C. Patrick Reynolds

1978–2025 年に発表

115
論文数
23,212
被引用数
85
h 指数
110
i10 指数

被引用数

C. Patrick Reynolds の年別被引用数1976 年: 被引用 1 件1979 年: 被引用 3 件1980 年: 被引用 1 件1981 年: 被引用 3 件1982 年: 被引用 4 件1984 年: 被引用 1 件1985 年: 被引用 8 件1986 年: 被引用 15 件1987 年: 被引用 7 件1988 年: 被引用 8 件1989 年: 被引用 12 件1990 年: 被引用 16 件1991 年: 被引用 16 件1992 年: 被引用 31 件1993 年: 被引用 50 件1994 年: 被引用 59 件1995 年: 被引用 70 件1996 年: 被引用 54 件1997 年: 被引用 64 件1998 年: 被引用 54 件1999 年: 被引用 65 件2000 年: 被引用 91 件2001 年: 被引用 103 件2002 年: 被引用 86 件2003 年: 被引用 110 件2004 年: 被引用 86 件2005 年: 被引用 74 件2006 年: 被引用 100 件2007 年: 被引用 117 件2008 年: 被引用 125 件2009 年: 被引用 148 件2010 年: 被引用 240 件2011 年: 被引用 212 件2012 年: 被引用 236 件2013 年: 被引用 202 件2014 年: 被引用 223 件2015 年: 被引用 230 件2016 年: 被引用 170 件2017 年: 被引用 182 件2018 年: 被引用 195 件2019 年: 被引用 624 件2020 年: 被引用 659 件2021 年: 被引用 593 件2022 年: 被引用 455 件2023 年: 被引用 274 件2024 年: 被引用 458 件2025 年: 被引用 173 件2026 年: 被引用 6 件1977〜1978 年は被引用が無いため表示していません1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,515 件、この内訳の 34.1%中国: 引用元論文 620 件、この内訳の 8.4%ドイツ: 引用元論文 421 件、この内訳の 5.7%イギリス: 引用元論文 386 件、この内訳の 5.2%イタリア: 引用元論文 345 件、この内訳の 4.7%フランス: 引用元論文 292 件、この内訳の 4%カナダ: 引用元論文 238 件、この内訳の 3.2%オーストラリア: 引用元論文 231 件、この内訳の 3.1%日本: 引用元論文 214 件、この内訳の 2.9%オランダ: 引用元論文 192 件、この内訳の 2.6%スペイン: 引用元論文 172 件、この内訳の 2.3%スイス: 引用元論文 157 件、この内訳の 2.1%
0%34.1%その他 21.7%

機関

分野

  • Medicine51.4%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology5.6%
  • Neuroscience2.1%
  • Materials Science1.4%
  • Engineering1.3%
  • その他3.6%

トピック

  • Neuroblastoma Research and Treatments9.5%
  • Cancer, Hypoxia, and Metabolism4.5%
  • CAR-T cell therapy research2.3%
  • Cancer therapeutics and mechanisms2.3%
  • Cell death mechanisms and regulation2.1%
  • Sarcoma Diagnosis and Treatment1.5%
  • その他77.8%

共著者

全論文

検索で開く
  1. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    著者: Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, Wendy B. London, Susan G. Kreissman, Helen X. Chen, Malcolm A. Smith, Barry Anderson, Judith G. Villablanca, Katherine K. Matthay, Hiro Shimada, Stephan A. Grupp, Robert C. Seeger, C. Patrick Reynolds, Allen Buxton, Ralph A. Reisfeld, S. D. Gillies, Susan L. Cohn, John M. Maris, Paul M. Sondel - New England Journal of Medicine 2010 被引用: 1,809

  2. Determination of subcutaneous tumor size in athymic (nude) mice

    著者: Mary M. Tomayko, C. Patrick Reynolds - Cancer Chemotherapy and Pharmacology 1989 被引用: 1,830

  3. Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

    著者: Min H. Kang, C. Patrick Reynolds - Clinical Cancer Research 2009 被引用: 1,021

  4. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    著者: Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger, Hiroyuki Shimada, E. Stanton Adkins, Daphne A. Haas‐Kogan, Robert B. Gerbing, Wendy B. London, Judith G. Villablanca - Journal of Clinical Oncology 2009 被引用: 856

  5. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

    著者: Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger, Daniel O. Stram, Richard E. Harris, Norma K.C. Ramsay, Patrick S. Swift, Hiroyuki Shimada, Charles T. Black, Garrett M. Brodeur, Robert B. Gerbing, C. Patrick Reynolds - New England Journal of Medicine 1999 被引用: 1,903

  6. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

    著者: Jo Lynne Harenza, Maura Diamond, Rebecca N. Adams, Michael M. Song, Heather L. Davidson, Lori S. Hart, Maiah H. Dent, Paolo Fortina, C. Patrick Reynolds, John M. Maris - Scientific Data 2017 被引用: 178

  7. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

    著者: Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas, Kristen Upton, Joy C. Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo López, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher L. Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yaël P. Mossé, Gregory J. Gatto, Yolanda Sánchez, Casey S. Greene, Sharon J. Diskin, Olena M. Vaske, David Haussler, Julie M. Gastier‐Foster, E. Anders Kolb, Richard Görlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris - Cell Reports 2019 被引用: 173

  8. Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    著者: Wendy B. London, R P Castleberry, Katherine K. Matthay, A. Thomas Look, Robert C. Seeger, Hiroyuki Shimada, Paul S. Thorner, G M Brodeur, John M. Maris, C. Patrick Reynolds, Susan L. Cohn - Journal of Clinical Oncology 2005 被引用: 587

  9. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

    著者: Mark Sausen, Rebecca Leary, Siân Jones, Jian Wu, C. Patrick Reynolds, Xueyuan Liu, Amanda L. Blackford, Giovanni Parmigiani, Luis A. Díaz, Nickolas Papadopoulos, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Michael D. Hogarty - Nature Genetics 2012 被引用: 415

  10. A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

    著者: Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho, Min H. Kang, Susan L. Cohn, Clarke P. Anderson, Araz Marachelian, Susan Groshen, Denice Tsao‐Wei, Katherine K. Matthay, John M. Maris, Charlotte E. Hasenauer, Scarlett Czarnecki, Hollie Lai, Fariba Goodarzian, Hiro Shimada, C. Patrick Reynolds - Pediatric Blood & Cancer 2016 被引用: 95

  11. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer

    著者: Veena Coothankandaswamy, Sha Cao, Ying Xu, Puttur D. Prasad, Pankaj K. Singh, C. Patrick Reynolds, Shengping Yang, Jiro Ogura, Vadivel Ganapathy, Yangzom D. Bhutia - British Journal of Pharmacology 2016 被引用: 136

  12. miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma

    著者: Srinivas Chava, C. Patrick Reynolds, Anup S. Pathania, Santhi Gorantla, Larisa Y. Poluektova, Donald W. Coulter, Subash C. Gupta, Manoj K. Pandey, Kishore B. Challagundla - Molecular Oncology 2019 被引用: 158

  13. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma

    著者: Carol J. Thiele, C. Patrick Reynolds, Mark A. Israel - Nature 1985 被引用: 649

  14. Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641

    著者: Douglas Strother, Wendy B. London, Mary Lou Schmidt, Garrett M. Brodeur, Hiroyuki Shimada, Paul S. Thorner, Margaret H. Collins, Edward P. Tagge, Stanton Adkins, C. Patrick Reynolds, Kevin Murray, Robert S. Lavey, Katherine K. Matthay, Robert P. Castleberry, John M. Maris, Susan L. Cohn - Journal of Clinical Oncology 2012 被引用: 239

  15. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma

    著者: Ashujit Tagde, Harpal Singh, Min H. Kang, C. Patrick Reynolds - Blood Cancer Journal 2014 被引用: 124

  16. Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression

    著者: Min H. Kang, Jing Wang, Monish Ram Makena, Joo-Sang Lee, Nancy Paz, Connor P. Hall, Michael M. Song, Ruben I. Calderon, Riza E. Cruz, Ashly Hindle, Winford Ko, Jonathan B. Fitzgerald, Daryl C. Drummond, Timothy J. Triche, C. Patrick Reynolds - Clinical Cancer Research 2015 被引用: 100

  17. ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156

    著者: Balakrishna Koneru, Ahsan Farooqi, Thinh H. Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A. Burrow, Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine Cadogan, Stephen T. Durant, C. Patrick Reynolds - Science Translational Medicine 2021 被引用: 58

  18. Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance

    著者: Jorida Çoku, David M. Booth, J. Škoda, Madison C Pedrotty, Jennifer Vogel, Kangning Liu, Annette Vu, Erica L. Carpenter, Jamie C. Ye, Michelle A. Chen, Peter J. Dunbar, Elizabeth O. Scadden, Taekyung D. Yun, Eiko Nakamaru‐Ogiso, Estela Área-Gómez, Yimei Li, Kelly C. Goldsmith, C. Patrick Reynolds, György Hajnóczky, Michael D. Hogarty - The EMBO Journal 2022 被引用: 31

  19. The pediatric preclinical testing program: Description of models and early testing results

    著者: Peter J. Houghton, Christopher L. Morton, Chandra L. Tucker, Debbie Payne, Edward Favours, Claire Cole, Richard Görlick, E. Anders Kolb, Wendong Zhang, Richard B. Lock, Hernán Carol, Mimi Tajbakhsh, C. Patrick Reynolds, John M. Maris, Joshua Courtright, Stephen T. Keir, Henry S. Friedman, Charles M. Stopford, Joseph Zeidner, Jianrong Wu, Tiebin Liu, Catherine A. Billups, Javed Khan, Sherry S. Ansher, Jian Zhang, Malcolm A. Smith - Pediatric Blood & Cancer 2006 被引用: 483

  20. The two different receptors for tumor necrosis factor mediate distinct cellular responses.

    著者: Louis A. Tartaglia, R F Weber, Irene S. Figari, C. Patrick Reynolds, Michael A. Palladino, David V. Goeddel - National Academy of Sciences, Proceedings of the National Academy of Sciences 1991 被引用: 814

  21. Retinoid therapy of high-risk neuroblastoma

    著者: C. Patrick Reynolds, Katherine K. Matthay, Judith G. Villablanca, Barry J. Maurer - Cancer Letters 2003 被引用: 335

  22. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

    著者: Balakrishna Koneru, Gonzalo López, Ahsan Farooqi, Karina L. Conkrite, Thinh H. Nguyen, Shawn J. Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, Heather L. Davidson, Kristyn McCoy, Jonas Nance, Vanda Yazdani, Meredith S. Irwin, Shengping Yang, David A. Wheeler, John M. Maris, Sharon J. Diskin, C. Patrick Reynolds - Cancer Research 2020 被引用: 112

  23. Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

    著者: Kateryna Krytska, Hannah T. Ryles, Renata Sano, Pichai Raman, Nicole R. Infarinato, Theodore D. Hansel, Monish Ram Makena, Michael M. Song, C. Patrick Reynolds, Yaël P. Mossé - Clinical Cancer Research 2015 被引用: 105

  24. Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

    著者: Caitlin D. Lowery, Michele Dowless, Matthew Renschler, Wayne Blosser, Alle B. VanWye, Jennifer R. Stephens, Philip W. Iversen, Aimee Bence Lin, Richard P. Beckmann, Kateryna Krytska, Kristina A. Cole, John M. Maris, Douglas S. Hawkins, Brian P. Rubin, Raushan T. Kurmasheva, Peter J. Houghton, Richard Görlick, E. Anders Kolb, Min H. Kang, C. Patrick Reynolds, Stephen W. Erickson, Beverly A. Teicher, Malcolm A. Smith, Louis F. Stancato - Clinical Cancer Research 2018 被引用: 80